Diet and Parkinson's disease II: A possible role for the past intake of specific nutrients: Results from a self-administered food-frequency questionnaire in a case-control study
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In a case-control study, we compared the past dietary habits of 342 Parkinson's disease (PD) patients recruited from nine German clinics with those of 342 controls from the same neighborhood or region. Data were gathered with a structured interview and a self-administered food-frequency questionnaire. Nutrient intakes were calculated from the reported food intakes through linkage with the German Federal Food Code and analyzed using multivariate conditional logistic regression to control for total energy intake, educational status, and cigarette smoking. At the macronutrient level, patients reported higher carbohydrate intake than controls after adjustment for total energy intake, smoking, and educational status (OR = 2.74, 95% confidence interval [CI]: 1.30-6.07, for the highest versus lowest quartile, p trend = 0.02). This was reflected in higher monosaccharide and disaccharide intakes at the nutrient level. There was no difference between patients and controls in protein and fat intake after adjustment for energy intake. We found an inverse association between the intakes of beta-carotene (OR = 0.67, 95% CI: 0.37-1.19, p trend = 0.06) and ascorbic acid (OR = 0.60, 95% CI: 0.33-1.09, p trend = 0.04) by patients, although only the trend for ascorbic acid intake reached statistical significance. There was no difference between groups for alpha-tocopherol intake after adjustment for energy intake. We also found that patients reported a significantly lower intake of niacin than controls (OR = 0.15, 95% CI: 0.07-0.33, p trend < 0.00005). Our results suggest that if antioxidants play a protective role in this disease, the amounts provided by diet alone are insufficient. Although the interpretation of the inverse association between niacin intake and PD is complicated by the high niacin content in coffee and alcoholic beverages, which were also inversely associated with PD in this study, the strength of this association and its biologic plausibility warrant further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
Riederer, P., Sofic, E., Rausch, W., Schmidt, B., Reynolds, G. P., Jellinger, K., & Youdim, M. B. H. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09150.x · Cited by 1,383
A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's disease
Fahn, S. (1992) · Annals of Neurology · doi:10.1002/ana.410320722 · Cited by 211
Research works printed but not linked: 38
- 10.1212/WNL.47.1_Suppl_1.6S · doi:10.1212/wnl.47.1_suppl_1.6s
- 10.1212/WNL.46.1.1 · DOI · Paper page
- Jessen RJ. Statistical survey techniques. New York: John Wiley and Sons 1978.
- Bohlscheid-Thomas S Hoting J Boeing H Wahrendorf J. Reproducibility and validity of food group intake of a food frequency questionnaire developed for the German part of the EPIC-project. Int J Epidemiol in press.
- Bohlscheid-Thomas S Hoting J Boeing H Wahrendorf J. Reproducibility and validity of energy and macronutrient intake of a food frequency questionnaire developed for the German part of the EPIC-project. Int J Epidemiol in press.
- Boeing H Bohlscheid-Thomas S Voss S Schneeweiss S Wahrendorf J. The relative validity of vitamin intakes derived from a food frequency questionnaire compared to 24-hr-recalls and biological measurements: Results from the EPIC pilot study in Germany. Int J Epidemiol in press.
- Willett W. Nutritional epidemiology. New York: Oxford University Press 1990.
- Schlesselman JJ. Case-control studies. Design conduct analysis. Oxford: Oxford University Press 1982.
- 10.1136/bmj.301.6742.1 · DOI
- 10.1212/WNL.41.1.1 · DOI · Paper page
- Jenner P, Dexter DT, Sian J, Schapira AHV, Marsden CD. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann Neurol 1992;32:S82-S87.
- Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 1992;32:804-812.
- Olanow CW. A radical hypothesis for neuronal degeneration. Trends Neurosci 1993;16:439-444.
- Dexter DT, Carter CJ, Wells FR, et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989;52:381-389.
- Saggu H, Cooksey J, Dexter D, et al. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 1989;53:692-697.
- Marttila RJ, Lorentz H, Rinne UK. Oxygen toxicity protecting enzymes in Parkinson's disease. J Neurol Sci 1988;86:321-331.
- 10.1002/ana.410350703 · DOI
- 10.1016/0165-0173(93)90005-K · DOI · Paper page
- 10.1002/ana.410230102 · DOI
- 10.1056/NEJM199301073280101 · DOI · Paper page
- 10.1016/S0033-3506(05)80323-3 · doi:10.1016/s0033-3506(05)80323-3
- Bender DA, Njagi ENM, Danielian PS. Tryptophan metabolism in vitamin B6-deficient mice. Br J Nutr 1990;63:27-36.
- Bender DA. Effects of a dietary excess of leucine and of the addition of leucine and 2-oxo-isocaproate on the metabolism of tryptophan and niacin in isolated rat liver cells. Br J Nutr 1989;61:629-640.
- Bender DA. Inhibition of tryptophan-niacin metabolism by dietary leucine and by leucine and 2-oxo-isocaproate in vitro. Adv Exp Med Biol 1991;294:501-504.
- 10.1046/j.1471-4159.1994.63010001.x · DOI
- Suzuki T, Fujita S, Narimatsu S, et al. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes. FASEB J 1992;6:771-776.
- 10.1016/0006-291X(87)91068-0 · doi:10.1016/0006-291x(87)91068-0
- Barbeau A, Roy M, Cloutier T, Plasse L, Paris S. Environmental and genetic factors in the etiology of Parkinson's disease. Adv Neurol 1986;45:299-306.
- Smith CAD, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992;339:1375-1377.
- Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992;339:1017-1018.
- Jimenez-Jimenez FJ, Tabernero C, Mena MA, et al. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a model of rat designated a poor metabolizer of debrisoquine. J Neurochem 1991;57:81-87.
- Birkmayer JGD, Birkmayer W. Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotide-phosphate (NADPH). Acta Neurol Scand 1989;126:183-187.
- Birkmayer W, Birkmayer JGD, Vrecko K, Paletta B. The clinical benefit of NADH as stimulator of endogenous L-dopa biosynthesis in parkinsonian patients. Adv Neurol 1990;53:545-549.
- Birkmayer W, Birkmayer JGD, Vrecko C, Paletta B, Reschenhofer E, Ott E. Nicotinamide adenine nucleotide (NADH) as medication for Parkinson's disease. Experience with 415 Patients. New Trends Clin Neuropharmacol 1990;4:7-24.
- Williams AC. Dopamine, dystonia, and the deficient cofactor. Lancet 1995;345:1130.
- Williams A, Sturman S, Steventon G, Waring R. Metabolic biomarkers of Parkinson's disease. Acta Neurol Scand 1991;84:Suppl 136:19-23.
- Hosmer DW Lemeshow S. Applied logistic regression. New York: Wiley 1989. · DOI · Paper page
- Sandyk R, Pardeshi R. Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patient. Int J Neurosci 1990;52:225-232.
Cited by
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
Incidence of Parkinson's Disease: Variation by Age, Gender, and Race/Ethnicity
Van Den Eeden, S. K. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg068 · Cited by 1,747
Epidemiology and etiology of Parkinson's disease: a review of the evidence
Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Ramassamy, C. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.06.025 · Cited by 682
Epidemiology of parkinson’s disease
Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640
The effect of macromolecular crowding on protein aggregation and amyloid fibril formation
Munishkina, L. A., Cooper, E. M., Uversky, V. N., & Fink, A. L. (2004) · Journal of Molecular Recognition · doi:10.1002/jmr.699 · Cited by 356
Paraquat exposure as an etiological factor of Parkinson's disease
Dinis-Oliveira, R. J., Remião, F., Carmo, H., Duarte, J. A., Navarro, A. S., Bastos, M. L., & Carvalho, F. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.05.012 · Cited by 329
ESPOSITO, E., ROTILIO, D., DIMATTEO, V, DIGIULIO, C., CACCHIO, M., & ALGERI, S. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00078-7 · Cited by 326
Uversky, V. N. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0937-z · Cited by 312
Weight loss in Parkinson's disease
Chen, H., Zhang, S. M., Hernán, M. A., Willett, W. C., & Ascherio, A. (2003) · Annals of Neurology · doi:10.1002/ana.10577 · Cited by 297
Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis
Etminan, M., Gill, S. S., & Samii, A. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70097-1 · Cited by 279
Parkinson’s disease risks associated with dietary iron, manganese, and other nutrient intakes
Powers, K. M., Smith-Weller, T., Franklin, G. M., Longstreth, W. T., Swanson, P. D., & Checkoway, H. (2003) · Neurology · doi:10.1212/01.wnl.0000068021.13945.7f · Cited by 268
Dietary fatty acids and the risk of Parkinson disease: The Rotterdam Study
de Lau, L. M. L., Bornebroek, M., Witteman, J. C. M., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2005) · Neurology · doi:10.1212/01.wnl.0000166038.67153.9f · Cited by 259
Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk
Zhang, S. M., Hernán, M. A., Chen, H., Spiegelman, D., Willett, W. C., & Ascherio, A. (2002) · Neurology · doi:10.1212/01.wnl.0000028688.75881.12 · Cited by 240
Smoking, alcohol, and coffee consumption preceding Parkinson’s disease: A case-control study
Benedetti, M. D., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2000) · Neurology · doi:10.1212/wnl.55.9.1350 · Cited by 234
Zheng, Y., Li, Y., Satija, A., Pan, A., Sotos-Prieto, M., Rimm, E., Willett, W. C., & Hu, F. B. (2019) · BMJ · doi:10.1136/bmj.l2110 · Cited by 211
Prospective study of coffee consumption and risk of Parkinson’s disease
Sääksjärvi, K., Knekt, P., Rissanen, H., Laaksonen, M. A., Reunanen, A., & Männistö, S. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602788 · Cited by 182
Risk factors for parkinson’s disease: The leisure world cohort study
Paganini-Hill, A. (2001) · Neuroepidemiology · doi:10.1159/000054770 · Cited by 159
Dietary fat intake, pesticide use, and Parkinson's disease
Kamel, F., Goldman, S. M., Umbach, D. M., Chen, H., Richardson, G., Barber, M. R., Meng, C., Marras, C., Korell, M., Kasten, M., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.09.023 · Cited by 127
“Results of case-control studies were more variable, with some showing an inverse and others a positive association [3,4,9,10].”
BackgroundResultDietary antioxidants and risk of Parkinson's disease in two population-based cohorts
Yang, F., Wolk, A., Håkansson, N., Pedersen, N. L., & Wirdefeldt, K. (2017) · Movement Disorders · doi:10.1002/mds.27120 · Cited by 116
The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis
Hong, C. T., Chan, L., & Bai, C.-H. (2020) · Nutrients · doi:10.3390/nu12061860 · Cited by 113
“Patients with PD are less frequent habitual consumers of caffeinated food [3,4].”
BackgroundIntake of antioxidant vitamins and risk of Parkinson's disease
Hughes, K. C., Gao, X., Kim, I. Y., Rimm, E. B., Wang, M., Weisskopf, M. G., Schwarzschild, M. A., & Ascherio, A. (2016) · Movement Disorders · doi:10.1002/mds.26819 · Cited by 110
“However, previous epidemiological studies in this area have tended to be small and results have been inconsistent.(6-17) Therefore, we prospectively examined associations between intake of vitamin E, vitamin C, carotenoids, and risk of PD in the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (…”
ResultCaloric Restriction Mimetics in Nutrition and Clinical Trials
Hofer, S. J., Davinelli, S., Bergmann, M., Scapagnini, G., & Madeo, F. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.717343 · Cited by 109
Physical activity and risk of Parkinson's disease: a prospective cohort study
Logroscino, G., Sesso, H. D., Paffenbarger, R. S., & Lee, I.-M. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.097170 · Cited by 105
Targeting the Progression of Parkinsons Disease
George, J., Mok, S., Moses, D., Wilkins, S., Bush, A., Cherny, R., & Finkelstein, D. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602814 · Cited by 77
“Interestingly, reports of dietary intake (such as high intakes of saturated fats and cholesterols) could possibly influence the susceptibility of developing PD [172, 173, 201, 253].”
BackgroundLehmann, S., Costa, A. C., Celardo, I., Loh, S. H. Y., & Martins, L. M. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.72 · Cited by 69
“In support of this finding, an association between PD and niacin levels has been reported in two case–control studies, which found that a niacin-rich diet conferred a decreased risk of developing PD after correcting for occupational and environmental factors.(31,32) Furthermore, PD medication is associated with niacin…”
ResultAlisky, J. M. (2005) · Nutritional Neuroscience · doi:10.1080/10284150500484638 · Cited by 38
“Some but not all epidemiological studies have shown that higher intake of niacin may reduce risk of developing Parkinson’s disease (Hellenbrand et al. 1996; Fall et al. 1999; Ross et al. 2000; Abbott et al. 2003).”
Background
Metadata
- Authors
- Hellenbrand, W., Boeing, H., Robra, B.-P., Seidler, A., Vieregge, P., Nischan, P., Joerg, J., Oertel, W. H., Schneider, E., & Ulm, G.
- Venue
- Neurology
- Published
- 1996-09
- Volume
- 47
- Issue
- 3
- Pages
- 644-650
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2160627990
- Cited by
- 195
- References
- 3
- FWCI
- 3.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.